A REVOLUTION IN weight loss is apparently underway. Last fall, the US Food and Drug Administration fast-tracked review of the diabetes drug tirzepatide-sold under the brand name Mounjarofor weight loss, after a clinical trial showed that people with a body mass index (BMI) labeled "overweight" or "obese" lost as much as 22.5 percent of their body weight on the highest dose. Upon approval, the weekly injectable will be the latest drug in a booming biomedical sector that aims to combat, if not cure, the problem of "excess" weight.
For pharmaceutical companies, the race to market is, as usual, financially motivated. Weight-loss drugs are rarely covered by insurance, and companies are finding plenty of patients ready to pay more than $1,000 a month for tirzepatide and its cousin semaglutide (brand names: Ozempic and Wegovy). Commentators have hailed these drugs as a "medical breakthrough" and a "silver bullet" for obesity; people from Hollywood to the Hamptons want a prescription. Now, doctors-desperate to treat what is widely seen as an "obesity epidemic" are showing interest.
But victorious narratives around drugs like Mounjaro pose a direct challenge to the fat activism movement. For decades, this movement has pushed for social and economic opportunity for people of all sizes using a variety of rhetorical modes-civil rights, fat pride and liberation, and biomedical evidence itself. Many people now know that "lifestyle changes" like calorie restriction and exercise fail to produce sustained weight loss for 97 percent of people and that many dieters end up gaining back more weight than they lost. But what happens to the strength of these arguments when a weight-loss drug seems to work?
This story is from the May 2023 edition of WIRED.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 2023 edition of WIRED.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Women at the Bottom of the World
They go to Antarctica with dreams of studying the unknown. What they discover there is the stuff of nightmares.
RUSSIAN, GO HOME
WHEN MY COUNTRY WENT TO WAR, I FACED A CHOICE: Flee to a world where the truth might kill me - or seek peace in censored oblivion.
The Fateful Eight
THE STORY BEHIND THE MOST CONSEQUENTIAL TECHNOLOGICAL PAPER IN RECENT HISTORY.
Can the Internet's Greatest Authenticity Machine Survive Wall Street?
When thousands of subreddits went dark in protest last summer, it exposed the tension at the core of Reddit - on the eve of the company's IPO. Now that synthetic media is flooding the internet, does the web's most reliably human forum represent a gold mine for investors, or an old-fashioned dumpster fire?
The Unnerving Presence of Javier Bardem
He's known for playing fanatics and murderous psychopaths. In real life, he loves his wife (and Brad Pitt) and cries during E.T.
HAPPY HAUNTING
IN A CHARMING game called This Discord Has Ghosts in It, up to 15 participants at a time gather in a Discord server that has been reimagined as a haunted house. (Of course.) Inside lies a maze of (chat) rooms where each player takes the role of either an eponymous spirit or a paranormal investigator.
THE MYTH OF METAL
How I became a Python programmer - and learned to love our abstract world.
SO YOU WANT TO REWIRE BRAINS
There's a lot to like about brain-computer interfaces, those sci-fi-sounding devices that jack into your skull and turn neural signals into software commands. Experimental BCIS help paralyzed people communicate, use the internet, and move prosthetic limbs.
FOR GIANT LIZARDS, PLEASE HOLD
The sounds of Slack have a secret history.
THE NERD-KING VIBES OF JENSEN HUANG
The Nvidia CEO turned a graphics-card company into a trillion-dollar AI behemoth. Now he wants to transform the rest of the world-health care, robotics, autonomous driving, the works.